These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 27127124)
41. Genetic polymorphisms of the interleukin-4 receptor alpha gene are associated with an increasing risk and a poor prognosis of sporadic renal cell carcinoma in a Japanese population. Nakamura E; Megumi Y; Kobayashi T; Kamoto T; Ishitoya S; Terachi T; Tachibana M; Matsushiro H; Habuchi T; Kakehi Y; Ogawa O Clin Cancer Res; 2002 Aug; 8(8):2620-5. PubMed ID: 12171893 [TBL] [Abstract][Full Text] [Related]
42. Polymorphism rs4787951 in IL-4R contributes to the increased risk of renal cell carcinoma in a Chinese population. Lin Y; Yuan Q; Qian F; Qin C; Cao Q; Wang M; Chu H; Zhang Z Gene; 2019 Feb; 685():242-247. PubMed ID: 30472377 [TBL] [Abstract][Full Text] [Related]
43. Association between the interleukin-6 gene polymorphisms and renal cancer risk. Liu Z; Wang Z; Xiao Y; Lu Y; Lu Y Immunol Lett; 2015 Apr; 164(2):125-8. PubMed ID: 25766682 [TBL] [Abstract][Full Text] [Related]
44. Vitamin D receptor gene polymorphisms are associated with increased risk and progression of renal cell carcinoma in a Japanese population. Obara W; Suzuki Y; Kato K; Tanji S; Konda R; Fujioka T Int J Urol; 2007 Jun; 14(6):483-7. PubMed ID: 17593089 [TBL] [Abstract][Full Text] [Related]
45. Polymorphisms in the IL-13 and IL-4R genes are associated with the development of renal cell carcinoma. Chu H; Wang M; Yan F; Zhong D; Shi D; Ma L; Pan X; Qin C; Yin C; Zhang Z Ann Oncol; 2012 Aug; 23(8):2114-2121. PubMed ID: 22317767 [TBL] [Abstract][Full Text] [Related]
46. Risk of renal cell carcinoma and polymorphism in phase I xenobiotic metabolizing CYP1A1 and CYP2D6 enzymes. Ahmad ST; Arjumand W; Seth A; Nafees S; Rashid S; Ali N; Hamiza OO; Sultana S Urol Oncol; 2013 Oct; 31(7):1350-7. PubMed ID: 22281432 [TBL] [Abstract][Full Text] [Related]
47. Investigation on the association between inerleukin-10 -592C/A, 819C/T and -1082A/G gene polymorphisms and development of diabetic nephrophathy. Yin Q; Zhai Q; Wang D; Hai J; Cao M; Wang J; Wang T Int J Clin Exp Pathol; 2015; 8(11):15216-21. PubMed ID: 26823869 [TBL] [Abstract][Full Text] [Related]
48. Predictive value of vascular endothelial growth factor polymorphisms on the risk of renal cell carcinomas. Xian W; Zheng H; Wu WJ Genet Mol Res; 2015 Jul; 14(3):7634-42. PubMed ID: 26214443 [TBL] [Abstract][Full Text] [Related]
49. Interleukin-4-receptor alpha gene polymorphism and the risk of renal cell carcinoma in a South Indian population. Mohan S; Mohanasenthil ; Paul SF; Shroff S; Venkatesan V Asian Pac J Cancer Prev; 2009; 10(2):295-8. PubMed ID: 19548368 [TBL] [Abstract][Full Text] [Related]
50. Impact of interleukin-18 polymorphisms-607 and -137 on clinical characteristics of renal cell carcinoma patients. Sáenz-López P; Carretero R; Vazquez F; Martin J; Sánchez E; Tallada M; Garrido F; Cózar JM; Ruiz-Cabello F Hum Immunol; 2010 Mar; 71(3):309-13. PubMed ID: 19961892 [TBL] [Abstract][Full Text] [Related]
51. Adiponectin gene polymorphisms and obesity increase the susceptibility to arsenic-related renal cell carcinoma. Hsueh YM; Chen WJ; Lin YC; Huang CY; Shiue HS; Yang SM; Ao PL; Pu YS; Su CT Toxicol Appl Pharmacol; 2018 Jul; 350():11-20. PubMed ID: 29723618 [TBL] [Abstract][Full Text] [Related]
53. Haplotype analysis of IL-10 gene polymorphism in couples with spontaneous abortions and aborted fetuses. Vidyadhari M; Sujatha M; Krupa P; Nallari P; Venkateshwari A Immunol Res; 2017 Aug; 65(4):853-861. PubMed ID: 28456881 [TBL] [Abstract][Full Text] [Related]
54. An association study of inflammatory cytokine gene polymorphisms in Fabry disease. Safyan R; Whybra C; Beck M; Elstein D; Altarescu G Eur Cytokine Netw; 2006 Dec; 17(4):271-5. PubMed ID: 17353161 [TBL] [Abstract][Full Text] [Related]
55. Combined effects of DNA methyltransferase 1 and 3A polymorphisms and urinary total arsenic levels on the risk for clear cell renal cell carcinoma. Yang SM; Huang CY; Shiue HS; Pu YS; Hsieh YH; Chen WJ; Lin YC; Hsueh YM Toxicol Appl Pharmacol; 2016 Aug; 305():103-110. PubMed ID: 27292127 [TBL] [Abstract][Full Text] [Related]
56. Genetic polymorphisms of interleukin 6 and interleukin 10 in Egyptian patients with systemic lupus eythematosus. Talaat RM; Alrefaey SA; Bassyouni IH; Ashour ME; Raouf AA Lupus; 2016 Mar; 25(3):255-64. PubMed ID: 26568585 [TBL] [Abstract][Full Text] [Related]
57. Impacts of Interleukin-10 Promoter Genotypes on Prostate Cancer. Chin YT; Tsai CL; Ma HH; Cheng DC; Tsai CW; Wang YC; Shih HY; Chang SY; Gu J; Chang WS; Bau DT Life (Basel); 2024 Aug; 14(8):. PubMed ID: 39202777 [TBL] [Abstract][Full Text] [Related]
58. Association Between 3 IL-10 Gene Polymorphisms and Cardiovascular Disease Risk: Systematic Review With Meta-Analysis and Trial Sequential Analysis. Xuan Y; Wang L; Zhi H; Li X; Wei P Medicine (Baltimore); 2016 Feb; 95(6):e2846. PubMed ID: 26871859 [TBL] [Abstract][Full Text] [Related]
59. Association between SNPs in vascular endothelial growth factor polymorphisms and risk of renal cell carcinoma: a case-control study. Shen BL; Qu QS; Miao SZ; Zhang YX Genet Mol Res; 2015 Sep; 14(3):11119-25. PubMed ID: 26400342 [TBL] [Abstract][Full Text] [Related]
60. Association of interleukin-10 gene promoter polymorphism in allergic patients. Gaddam SL; Priya VH; Babu BM; Joshi L; Venkatasubramanian S; Valluri V Genet Test Mol Biomarkers; 2012 Jun; 16(6):632-5. PubMed ID: 22715992 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]